Key result
The transition from mercury sphygmomanometers to automated blood pressure devices necessitates independent validation of the new technologies for accuracy.
Highlights the transition from mercury sphygmomanometers to automated blood pressure devices and emphasizes the need for independent validation using standardized protocols.
After a little more than a century of use, the conventional Riva-Rocci/Korotkoff technique of measuring blood pressure with a mercury sphygmomanometer and stethoscope, is now being relegated to the museum shelves. Affectionately attached though we may be to this clinical measurement, we must acknowledge that the technique is fraught with inaccuracy and that the age of technology has brought more accurate alternative methodologies. However, we must ensure that the automated devices that are replacing the conventional technique are validated independently for accuracy. The Working Group on Blood Pressure Monitoring of the European Society of Hypertension has recently published an International Protocol to facilitate the validation of more automated devices than was possible with the earlier more complicated protocols.
No takes yet. Share an insight, caveat, or question.
Eoin OʼBrien (2003) conducted an editorial in Blood pressure measurement. Automated blood pressure devices vs. Mercury sphygmomanometer was evaluated. The transition from mercury sphygmomanometers to automated blood pressure devices necessitates independent validation of the new technologies for accuracy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: